Rondo Therapeutics Overview

  • Founded
  • 2020
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $67M
Latest Deal Amount
  • Investors
  • 5

Rondo Therapeutics General Information

Description

Developer of bispecific therapeutic antibodies designed to control activation of the immune system to fight cancer. The company is engaged in developing cancer immunotherapies for solid tumor types that fail to respond to immune checkpoint inhibitors, enabling researchers to focus on the advancement of novel drugs in areas of unmet medical needs.

Contact Information

Website
www.rondotx.com
Formerly Known As
Seismic Bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 23860 Twin Creeks Court
  • Hayward, CA 94541
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rondo Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 02-Mar-2022 $67M 0000 0000 Completed Generating Revenue
1. Angel (individual) Completed Startup
To view Rondo Therapeutics’s complete valuation and funding history, request access »

Rondo Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1 0,000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
To view Rondo Therapeutics’s complete cap table history, request access »

Rondo Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Shelley Aldred Ph.D Co-Founder & Chief Executive Officer
Nathan Trinklein Ph.D Co-Founder, President & Chief Scientific Officer
To view Rondo Therapeutics’s complete executive team members history, request access »

Rondo Therapeutics Board Members (2)

Name Representing Role Since
Jon Edwards Ph.D Red Tree Venture Capital Board Member 000 0000
Nina Kjellson Canaan Partners Board Member 000 0000
To view Rondo Therapeutics’s complete board members history, request access »

Rondo Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rondo Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Canaan Partners Venture Capital Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
Novo Holdings Venture Capital Minority 000 0000 000000 0
Red Tree Venture Capital Venture Capital Minority 000 0000 000000 0
SV Health Investors Venture Capital Minority 000 0000 000000 0
To view Rondo Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial